Your browser doesn't support javascript.
loading
CAR T-cell product performance in haematological malignancies before and after marketing authorisation.
Elsallab, Magdi; Levine, Bruce L; Wayne, Alan S; Abou-El-Enein, Mohamed.
Afiliação
  • Elsallab M; Berlin Institute of Health Center for Regenerative Therapies, Charité-Universitatsmedizin Berlin, Berlin, Germany.
  • Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Wayne AS; Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, CA, USA; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Abou-El-Enein M; Berlin Institute of Health Center for Regenerative Therapies, Charité-Universitatsmedizin Berlin, Berlin, Germany; Berlin Center for Advanced Therapies, Charité-Universitatsmedizin Berlin, Berlin, Germany. Electronic address: mohamed.abou-el-enein@charite.de.
Lancet Oncol ; 21(2): e104-e116, 2020 02.
Article em En | MEDLINE | ID: mdl-32007196
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Antígenos CD19 / Neoplasias Hematológicas / Marketing Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Antígenos CD19 / Neoplasias Hematológicas / Marketing Idioma: En Ano de publicação: 2020 Tipo de documento: Article